| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -4.44% | -1.03% | -3.41% | -3.41% | — |
| 14d | 2 | +100.00% | -5.63% | -2.15% | -3.47% | -3.47% | — |
| 30d | 2 | +100.00% | -5.71% | +3.52% | -9.23% | -9.23% | — |
| 60d | 2 | +0.00% | +0.93% | +10.49% | -9.56% | -9.56% | — |
| 90d | 2 | +100.00% | -5.39% | +11.42% | -16.81% | -16.81% | — |
| 180d | 2(2 pending) | — | — | — | — | — | — |
| 1y | 2(2 pending) | — | — | — | — | — | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE10b5-1 10b5-1 plan | 13,976 | $34.92 | $488.1K | 77,071 | Mar 18, 2026 | Mar 20, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP & General Counsel | 8,840 | $35.72 | $315.8K | 68,231 | Mar 17, 2026 | Apr 3, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE10b5-1 10b5-1 plan | 6,224 | $36.65 | $228.1K | 91,047 | Mar 9, 2026 | Mar 11, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 9,005 | — | — | 100,052 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 22,194 | — | — | 91,047 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | SALE EVP & General Counsel | 2,781 | $46.75 | $130.0K | 97,271 | Feb 10, 2026 | Feb 12, 2026 ↗ | View → |
| COLL COLLEGIUM PHARMACEUTICAL, INC | PURCHASEGRANT Stock grant | 68,449 | — | — | 68,449 | Mar 17, 2025 | Mar 19, 2025 ↗ | View → |